Arya Sciences Acquisition IV EBIT

The latest EBIT for ARYD is $-5M as of March 2024. That compares with $-1.7M in the prior-year period — down 190.5% year over year. That is above the sector sector average of $-63M. Investors often review this figure alongside Arya Sciences Acquisition IV's historical trend and sector peers before judging valuation or financial health.

Over the past year, ARYD's EBIT moved from $-1.7M to $-5M — a 190.5% year-over-year decrease. If the trend continues in the same direction for several quarters, it can signal a meaningful shift in Arya Sciences Acquisition IV's operating scale or balance-sheet position.

Against its sector companies, ARYD currently prints $-5M for EBIT, while the sector average sits near $-63M. That is roughly 92.0% above the sector mean. Large gaps often invite a closer look at Arya Sciences Acquisition IV's growth, margins, and balance sheet.

A EBIT figure of $-5M for ARYD is a snapshot of scale on that line item. On its own it does not say whether the business is healthy — you also want growth rate, margins, and how the number compares with similar companies. The sector average is about $-63M. Explore the charts below for those layers of context.

After noting ARYD's EBIT ($-5M), review year-over-year change from $-1.7M, peer averages, and a few neighboring metrics such as revenue, margins, or valuation multiples. That combination usually beats staring at a single figure. The navigation links on this page jump you to those related views.